Close menu




September 28th, 2020 | 15:09 CEST

BYD, Plug Power, Scottie Resources: Who has the best track record?

  • Investments
Photo credits: pixabay.com

Various sectors of the stock market are of particular interest to investors at the moment. Mobility is an engaging subject for people all around the globe. All developments are closely scrutinised, resulting in progress being rewarded by increased investor interest. When regress and uncertainty are detected, investors react like a shy deer and scatter. There are numerous opportunities to invest in and the time spent on shares is a critical factor, especially for stockholders. As always, it is worth taking a broad perspective.

time to read: 2 minutes | Author: Mario Hose
ISIN: CA81012R1064 , CNE100000296 , US72919P2020

Table of contents:


    The oldest currency in the world is in demand

    In the Canadian province of British Columbia, Scottie Resources is looking for new gold deposits. The company's projects are located in the so-called Golden Triangle, a region that has made a name for itself with its numerous deposits. Scottie Resources owns the Scottie Gold Mine of the same name in the region, which has produced gold in the past. The company has now secured 24,589 hectares of claims in the Golden Triangle.

    In a recent announcement, Scottie Resources has announced further airborne work to identify priorities for further ground exploration. In northern British Columbia, an area of 57 km2 is the focus of the surveys. The airborne geophysical surveys will provide interpretations that, in conjunction with sampling and geological mapping, will facilitate subsequent exploration.

    CEO Bradley Rourke provides further details: "Scottie Resources continues to aggressively explore and develop the Scottie Gold Mine Project. These geophysical surveys will enhance our technical data and understanding for future drill targeting. Drill progress has been better than expected and over 4,500 metres has been completed to date. Drill results will be released upon receipt."

    Is the comparison with Tesla justified?

    The BYD shares are currently in great demand. This interest is driven by the analysts' assessments and the company's announcements. The company recently announced that it had received an order for 106 electric buses from the Finnish transport company Nobina. The major customer will operate 64 vehicles in Helsinki and 42 in Turku.

    The Chinese group BYD is often compared to Tesla because the company serves the electromobility market with different vehicle models. Besides electric buses, BYD also offers limousines. The model 'Han' is said to have a range of up to 605 kilometres and to have 494 hp as a luxury version.

    Does growth also work at a profit?

    The US company, Plug Power, is a pioneer of the hydrogen ecosystem and can provide a variety of components for an infrastructure. In a growing market in which innovations are tested and, if successful, demanded in large quantities, there are attractive return opportunities for investors in well-positioned companies.

    Plug Power's share price has already performed well, but this does not mean that the price rally must end now. Given that the company is already valued at over EUR 4 billion, investors need to bear in mind that at a certain point there is a growing interest in profitability and that the market capitalization must be competitive. It is a significant industry phenomenon that in the current situation, where there is little supply on the market, companies still do not make money.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Mario Hose

    Mario Hose

    Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read